Knights Of Columbus Asset Advisors LLC Viridian Therapeutics, Inc.\De Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.47 Billion
- Q4 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 57,711 shares of VRDN stock, worth $896,828. This represents 0.08% of its overall portfolio holdings.
Number of Shares
57,711
Previous 57,565
0.25%
Holding current value
$896,828
Previous $1.31 Million
15.51%
% of portfolio
0.08%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding VRDN
# of Institutions
200Shares Held
79.4MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$74.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$71.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$70.3 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$60.3 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$54.7 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $620M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...